Skip to main content
Clinical Trials/CTRI/2024/05/067792
CTRI/2024/05/067792
Not yet recruiting
Phase 3

An Open Label Prospective Interventional Pragmatic Study to assess the effectiveness of Individualized Homoeopathic Medicine in Alopecia Areata - NI

Dr Asmita Dutta0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L639- Alopecia areata, unspecified
Sponsor
Dr Asmita Dutta
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Asmita Dutta

Eligibility Criteria

Inclusion Criteria

  • Patients fulfilling the diagnostic criteria of alopecia areata.
  • \-Patients using internal medication and topical agents from conventional medicines for alopecia areata will be included after a washout period of 15 days.
  • \-Patients who give consent for study and administration of homoeopathic medicine.

Exclusion Criteria

  • \-Patients with uncontrolled systemic and neurological illness.
  • \-Patients who are terminally ill, under immunosuppressive treatment or self\-reported immunocompromised state.
  • \-Diagnosed case of unstable mental or psychiatric illness or other uncontrolled or life\-threatening illness affecting quality of life or any organ failure.
  • \-Pregnant and lactating women.
  • \-Unwilling to take part and not giving consent to join the study.
  • \-Substance abuse and or dependence.

Outcomes

Primary Outcomes

Not specified

Similar Trials